Riverhead Capital Management’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-9,701
Closed -$62K 1571
2018
Q2
$62K Hold
9,701
﹤0.01% 1434
2018
Q1
$68K Buy
9,701
+200
+2% +$2.33K ﹤0.01% 1423
2017
Q4
$120K Buy
9,501
+1,400
+17% +$17.1K 0.01% 1278
2017
Q3
$96K Buy
8,101
+1,578
+24% +$23.4K ﹤0.01% 1287
2017
Q2
$98K Buy
6,523
+3,123
+92% +$41.7K ﹤0.01% 1228
2017
Q1
$32K Sell
3,400
-200
-6% -$1.69K ﹤0.01% 1380
2016
Q4
$32K Hold
3,600
﹤0.01% 1347
2016
Q3
$31K Sell
3,600
-4,100
-53% -$32.5K ﹤0.01% 1306
2016
Q2
$819K Sell
7,700
-10,525
-58% -$81.9K 0.03% 479
2016
Q1
$159K Sell
18,225
-6,075
-25% -$50.5K ﹤0.01% 1295
2015
Q4
$228K Buy
24,300
+18,200
+298% +$158K ﹤0.01% 1230
2015
Q3
$59K Buy
+6,100
New +$64.4K ﹤0.01% 1201

Other funds holding MDXG

Riverhead Capital Management's MDXG Position: Q3 2018 in Review

Riverhead Capital Management sold out of MiMedx Group (MDXG) in Q3 2018, closing a stake of 9,701 shares — an estimated $62K sold.

Riverhead Capital Management first reported a position in MDXG in Q3 2015 and held it in 12 quarters. The position peaked at $819K in Q2 2016. 186 funds tracked by Wall St. Rank hold MDXG as of Q3 2018.

  • Riverhead Capital Management reported no remaining MiMedx Group position as of Q3 2018 after selling out during the quarter.
  • Riverhead Capital Management sold 9,701 MiMedx Group shares in Q3 2018, an estimated $62K.
  • Riverhead Capital Management first reported a position in MiMedx Group in Q3 2015 and held it in 12 quarters.
  • Riverhead Capital Management's MiMedx Group position peaked at $819K in Q2 2016.
  • 186 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2018.

Based on Riverhead Capital Management's 13F filing for Q3 2018, filed 13 Nov 2018.